These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26499800)

  • 1. Coupling between Nutrient Availability and Thyroid Hormone Activation.
    Lartey LJ; Werneck-de-Castro JP; O-Sullivan I; Unterman TG; Bianco AC
    J Biol Chem; 2015 Dec; 290(51):30551-61. PubMed ID: 26499800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
    Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
    J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rictor, an mTORC2 Protein, Regulates Murine Lymphatic Valve Formation Through the AKT-FOXO1 Signaling.
    Banerjee R; Knauer LA; Iyer D; Barlow SE; Shalaby H; Dehghan R; Scallan JP; Yang Y
    Arterioscler Thromb Vasc Biol; 2024 Sep; 44(9):2004-2023. PubMed ID: 39087350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin A protects cells from apoptosis by regulating FoxO1 and mTORC1 through the OX1R/PI3K/AKT signaling pathway in hepatocytes.
    Ju SJ; Zhao Y; Chang X; Guo L
    Int J Mol Med; 2014 Jul; 34(1):153-9. PubMed ID: 24807827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway.
    Tan SH; Shui G; Zhou J; Shi Y; Huang J; Xia D; Wenk MR; Shen HM
    Autophagy; 2014 Feb; 10(2):226-42. PubMed ID: 24296537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
    Tripathy S; Jump DB
    J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
    Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX
    J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone activation by type 2 deiodinase mediates exercise-induced peroxisome proliferator-activated receptor-γ coactivator-1α expression in skeletal muscle.
    Bocco BM; Louzada RA; Silvestre DH; Santos MC; Anne-Palmer E; Rangel IF; Abdalla S; Ferreira AC; Ribeiro MO; Gereben B; Carvalho DP; Bianco AC; Werneck-de-Castro JP
    J Physiol; 2016 Sep; 594(18):5255-69. PubMed ID: 27302464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer.
    Zheng G; Jia X; Peng C; Deng Y; Yin J; Zhang Z; Li N; Deng M; Liu X; Liu H; Lu M; Wang C; Gu Y; He Z
    Oncotarget; 2015 Mar; 6(9):6931-43. PubMed ID: 25749387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1.
    Brown J; Wang H; Suttles J; Graves DT; Martin M
    J Biol Chem; 2011 Dec; 286(52):44295-305. PubMed ID: 22045807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.
    Zhao M; Luo R; Liu Y; Gao L; Fu Z; Fu Q; Luo X; Chen Y; Deng X; Liang Z; Li X; Cheng C; Liu Z; Fang W
    Nat Commun; 2016 Apr; 7():11309. PubMed ID: 27095304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes.
    Naïmi M; Gautier N; Chaussade C; Valverde AM; Accili D; Van Obberghen E
    Endocrinology; 2007 May; 148(5):2424-34. PubMed ID: 17303659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the PI3K-Akt and mTORC1 signaling pathways promotes the elongation of vascular endothelial cells.
    Tsuji-Tamura K; Ogawa M
    J Cell Sci; 2016 Mar; 129(6):1165-78. PubMed ID: 26826185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B cells.
    Lazorchak AS; Liu D; Facchinetti V; Di Lorenzo A; Sessa WC; Schatz DG; Su B
    Mol Cell; 2010 Aug; 39(3):433-43. PubMed ID: 20705244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation.
    Kowalsky AH; Namkoong S; Mettetal E; Park HW; Kazyken D; Fingar DC; Lee JH
    J Biol Chem; 2020 Feb; 295(7):1769-1780. PubMed ID: 31915252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone (T
    Yau WW; Singh BK; Lesmana R; Zhou J; Sinha RA; Wong KA; Wu Y; Bay BH; Sugii S; Sun L; Yen PM
    Autophagy; 2019 Jan; 15(1):131-150. PubMed ID: 30209975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components.
    Wu AL; Kim JH; Zhang C; Unterman TG; Chen J
    Endocrinology; 2008 Mar; 149(3):1407-14. PubMed ID: 18079193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
    Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
    Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
    Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
    Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity.
    Sajan MP; Acevedo-Duncan ME; Standaert ML; Ivey RA; Lee M; Farese RV
    Diabetes; 2014 Aug; 63(8):2690-701. PubMed ID: 24705403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.